VEGFRs are highly expressed in areas of neoangiogenesis, such as in the endothelial cells of tumour vasculature, a restricted distribution that may be exploited to provide targeted therapy, using VEGF as a delivery molecule. Here, VEGFA is linked to neoplasm.